Morgan Stanley’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$391K Buy
128,915
+62,700
+95% +$190K ﹤0.01% 5575
2025
Q1
$282K Sell
66,215
-33,312
-33% -$142K ﹤0.01% 5587
2024
Q4
$526K Buy
+99,527
New +$526K ﹤0.01% 5397
2023
Q2
Sell
-58,364
Closed -$183K 7703
2023
Q1
$183K Buy
58,364
+58,339
+233,356% +$183K ﹤0.01% 5740
2022
Q4
$67 Sell
25
-219
-90% -$587 ﹤0.01% 7719
2022
Q3
$1K Sell
244
-2,210
-90% -$9.06K ﹤0.01% 7605
2022
Q2
$7K Sell
2,454
-4,102
-63% -$11.7K ﹤0.01% 7328
2022
Q1
$33K Sell
6,556
-21,344
-77% -$107K ﹤0.01% 6904
2021
Q4
$188K Buy
27,900
+1,318
+5% +$8.88K ﹤0.01% 6110
2021
Q3
$184K Sell
26,582
-22,302
-46% -$154K ﹤0.01% 6046
2021
Q2
$475K Buy
48,884
+47,528
+3,505% +$462K ﹤0.01% 5556
2021
Q1
$21K Sell
1,356
-4,148
-75% -$64.2K ﹤0.01% 6701
2020
Q4
$134K Buy
5,504
+5,270
+2,252% +$128K ﹤0.01% 5789
2020
Q3
$4K Sell
234
-419
-64% -$7.16K ﹤0.01% 6482
2020
Q2
$19K Buy
653
+537
+463% +$15.6K ﹤0.01% 6022
2020
Q1
$3K Buy
+116
New +$3K ﹤0.01% 6341
2019
Q3
Sell
-3
Closed 6754
2019
Q2
$0 Sell
3
-248
-99% ﹤0.01% 6745
2019
Q1
$5K Sell
251
-829
-77% -$16.5K ﹤0.01% 6328
2018
Q4
$98K Buy
1,080
+1,069
+9,718% +$97K ﹤0.01% 5569
2018
Q3
$1K Buy
+11
New +$1K ﹤0.01% 6650
2018
Q2
Sell
-10
Closed -$1K 6752
2018
Q1
$1K Buy
+10
New +$1K ﹤0.01% 6557
2017
Q4
Hold
0
6649
2017
Q3
Sell
-8
Closed 6614
2017
Q2
$0 Buy
+8
New ﹤0.01% 6654
2016
Q4
Sell
-66
Closed -$24K 6565
2016
Q3
$24K Sell
66
-12
-15% -$4.36K ﹤0.01% 5857
2016
Q2
$25K Buy
78
+5
+7% +$1.6K ﹤0.01% 5777
2016
Q1
$22K Sell
73
-97
-57% -$29.2K ﹤0.01% 5890
2015
Q4
$106K Buy
170
+93
+121% +$58K ﹤0.01% 5374
2015
Q3
$43K Sell
77
-97
-56% -$54.2K ﹤0.01% 5793
2015
Q2
$124K Buy
174
+166
+2,075% +$118K ﹤0.01% 5476
2015
Q1
$3K Sell
8
-5
-38% -$1.88K ﹤0.01% 6403
2014
Q4
$5K Buy
+13
New +$5K ﹤0.01% 6339